Male Contraception Initiative RFA is Now Open


MCI’s 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and development. MCI intends to fund up to five grants, ranging from $150,000 to $300,000 over two years. MCI’s Priority Research Areas include:

● Post-meiotic phase of spermatogenesis
● Sperm functions required for normal fertilization, such as sperm motility and the
acrosome reaction
● Post-testicular processes required for fertility, including epididymal maturation and sperm
transport in the excurrent ducts
● Other processes that lead to fast-acting, reversible male contraceptives
● The potential for Multipurpose Prevention Technology (MPT) products acting against
sexually transmitted infections

Application are due by May 31, 2019. Additional information and the application can be found here.


Categorised in: Acceptability & Product Design, Funders, Funding, Male Contraception, Methods

Leave a Reply

Your email address will not be published. Required fields are marked *